Citizen Stash Expands Its Flower Product Line Up in B.C.
Citizen Stash Cannabis Corp. (OTCQB: EXPFF) announces the launch of Fruity Pebbles OG (FPOG) in British Columbia, expanding its product line with additional 3.5-gram flower jars and half-gram pre-rolls. These products will be available in retail outlets and online starting July. FPOG, an indica-dominant hybrid, is known for its sweet, tropical flavor. The company emphasizes its focus on innovation and expanding market presence while maintaining high-quality standards. This move reflects increasing consumer demand for Citizen Stash’s premium offerings.
- Launch of Fruity Pebbles OG in BC indicates product innovation.
- New SKUs awarded highlight demand for Citizen Stash products.
- Focus on expanding product offerings in existing and new markets.
- None.
VANCOUVER, BC / ACCESSWIRE / June 21, 2021 / Citizen Stash Cannabis Corp. (Formally Experion Holdings Ltd.) (the "Company" or "Citizen Stash") (TSXV:CSC)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and premium products is pleased to announce the launch of FPOG (Fruity Pebbles OG) into the British Columbia market starting this month.
As Citizen Stash continues to build a solid reputation for quality and consumer appeal, the Company was recently awarded an additional two new SKUs to the B.C. market that includes Fruity Pebbles OG 3.5-gram flower jars and two half-gram pre-rolls. The new products will be available for sale in retail stores in B.C. and online through the BC Cannabis stores in early July, and is further evidence of the demand for Citizen Stash products.
FPOG is an indica dominant hybrid that is a cross between Green Ribbon, Granddaddy Purple and Tahoe Alien and has sweet tropical scents of citrus and berries that provides a sugary, fruity aftertaste providing a premium experience for the consumer. As with all Citizen Stash strains, FPOG is hand harvested, hand trimmed, and expertly cured in small batches without the use of pesticides.
"One of our core competencies is our focus on continuous innovation in identifying and launching exciting new strains that have mass consumer appeal. We are able to successfully launch innovative new products and strains under our Citizen Stash brand as we are highly connected to the cannabis community and have a deep consumer connection that drives our innovation process", commented Mr. Jarrett Malnarich, CEO of Citizen Stash. "As provincial exchanges move to streamline their inventories and tighten SKU registrations, Citizen Stash is in the fortunate position to be adding new products in the B.C. market. Our focus remains expanding the shelf space for our Citizen Stash product portfolio within our current markets, while also continuing to aggressively pursue expansion opportunities into new provincial markets over the coming quarters."
About Citizen Stash Cannabis Corp.
Citizen Stash is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, B.C.
Citizen Stash is best known as a rapidly growing adult-use premium cannabis brand offered nationally in 7 provinces and territories. Citizen Stash has invested and developed a portfolio of premium cannabis genetics, strains and products with a unique growth strategy incorporating a highly scalable aggregation and distribution business model to drive revenues across its national sales network.
Citizen Stash trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol "CSC" on the OTCQB Venture under the symbol "EXPFF" and on the Frankfurt Stock Exchange under the symbol "MB31".
For further information, please visit the Company's website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com.
Disclosure
This news release contains "forward-looking statements" and "forward-looking information" (collectively referred to herein as "forward-looking statements") within the meaning of applicable securities legislation. Such forward-looking statements include, without limitation, forecasts, estimates, expectations and objectives for future operations that are subject to a number of material factors, assumptions, risks and uncertainties, many of which are beyond the control of the Company.
Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "continues", "future", "forecasts", "potential", "outlook" and similar expressions, or are events or conditions that "will", "would", "may", "likely", "could", "should", "can", "typically", "traditionally" or "tends to" occur or be achieved. This news release contains forward-looking statements, pertaining to, among other things, the following: The Company's capital spending forecast and expectations of how it will be funded; near-term impacts from the COVID-19 pandemic; the Company's capital management strategy and financial position; the impact of governmental and Company measures implemented in response to the COVID-19 pandemic; the Company's outlook, activity levels, supply chains and sales channels; loss of markets; further legislative and regulatory developments involving cannabis or otherwise affecting the Company's business or its consumers generally, including delays in the issuance of licenses; competition; currency and interest rate fluctuations; and marketing costs.
Although the Company believes that the material factors, expectations and assumptions expressed in such forward-looking statements are reasonable based on information available to it on the date such statements are made, undue reliance should not be placed on the forward-looking statements because the Company can give no assurances that such statements and information will prove to be correct and such statements are not guarantees of future performance. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.
Actual performance and results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to: known and unknown risks, including those set forth in the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis ("MD&A") (a copy of which can be found under Experion's profile on SEDAR at www.sedar.com); a significant expansion of COVID-19 pandemic and the impacts thereof; the Company's ability to raise the necessary capital or to be fully able to implement its business strategy; integration of acquisitions, competition, and uncertainties resulting from potential delays or changes in plans with respect to acquisitions, development projects or capital expenditures and changes in legislation; stock market volatility and the inability to access sufficient capital from external and internal sources; general economic, market or business conditions including those in the event of an epidemic, natural disaster or other event; global economic events; changes to the Company's financial position and cash flow; the availability of qualified personnel, management or other key inputs; currency exchange fluctuations; changes in political and security stability; potential industry developments; and other unforeseen conditions which could impact the Company. Accordingly, readers should not place undue importance or reliance on the forward-looking statements. Readers are cautioned that the foregoing list of factors is not exhaustive and should refer to "Risk Factors" set out in the MD&A.
Statements, including forward-looking statements, contained in this news release are made as of the date they are given and the Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Citizen Stash Cannabis Corp.
View source version on accesswire.com:
https://www.accesswire.com/652432/Citizen-Stash-Expands-Its-Flower-Product-Line-Up-in-BC
FAQ
What new products is Citizen Stash launching in BC?
When will the new products be available for sale?
What is the significance of the Fruity Pebbles OG strain?
How does the launch impact Citizen Stash's market presence?
What are the stock symbols for Citizen Stash Cannabis Corp.?
